Ronald Perrone
Nephrology · Boston, MANPI 1265541155
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $84,092 of the $110,380 with a category attached, or 76.2%. 13 manufacturers reported payments, led by Otsuka Pharmaceutical Development & Commercialization, Inc. at 44.7% of the total. Reporting peaked in 2019 at $29,389 and has fallen 58.0% since, to $12,337 in 2025. Among nephrology clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 85 payments — averaging $1298.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka Pharmaceutical Development & Commercialization, Inc.$49K
- Otsuka Pharmaceutical Co., Ltd.$24K
- Sanofi$11K
- AbbVie$8K
- Vertex$8K
- Otsuka America Pharmaceutical, Inc.$7K
- plus $3K from 7 others
Across 48 payments — averaging $9327.68 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Kadmon Corporation LLC$189K
- Sanofi$128K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$63K
- AbbVie$28K
- Biogen$27K
- Sanofi US Services Inc.$13K
What the payments were for
- Consulting fees$84,09276%
- Speaking & faculty fees$10,2889%
- Travel & lodging$14,99814%
- Food & beverage$9991%
- Education$30%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 19 | $49,372 |
| Otsuka Pharmaceutical Co., Ltd. | 27 | $23,754 |
| Sanofi | 5 | $11,423 |
| AbbVie | 3 | $7,815 |
| Vertex | 7 | $7,669 |
| Otsuka America Pharmaceutical, Inc. | 13 | $6,875 |
| Janssen Research & Development, LLC | 1 | $1,215 |
| Ipsen Biopharmaceuticals, Inc | 1 | $1,133 |
| ZOLL Medical Corporation | 1 | $508 |
| Sanofi-aventis U.S. LLC | 1 | $345 |
| Novartis | 1 | $139 |
| Janssen Scientific Affairs, LLC | 4 | $127 |
| Travere Therapeutics, Inc. | 2 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$110,380 in reported general payments places this provider in the 95th percentile of 339 nephrology providers in Massachusetts.
Other nephrology in Boston
- David FriedmanBoston$19.8M
- Martin PollakBoston$19.8M
- Dennis AusielloBoston$4.6M
- Ajay SinghBoston$916K
- Leslie FangBoston$388K
- Jean FrancisBoston$244K
- Joseph BonventreBoston$175K
- Andrew AllegrettiBoston$139K
- Ravi ThadhaniBoston$115K
- Meghan SiseBoston$113K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.